350 related articles for article (PubMed ID: 2025794)
1. A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure.
Pflugfelder PW; O'Neill BJ; Ogilvie RI; Beanlands DS; Tanser PH; Tihal H; Mizgala HF; Fitchett DH; Kostuk WJ
Can J Cardiol; 1991; 7(1):5-10. PubMed ID: 2025794
[TBL] [Abstract][Full Text] [Related]
2. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
Varriale P; Ramaprasad S
Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
[TBL] [Abstract][Full Text] [Related]
3. [Hemodynamic study of intravenous milrinone in 26 patients with NYHA class III or IV cardiac failure].
Boesch C; Dubois-Rande JL; Pochmalicki G; Lellouche D; Teiger E; Saal JP; Cachin JC; Mallo C; Castaigne A; Jan F
Ann Cardiol Angeiol (Paris); 1992 Nov; 41(9):509-12. PubMed ID: 1298193
[TBL] [Abstract][Full Text] [Related]
4. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
[TBL] [Abstract][Full Text] [Related]
5. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH
Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247
[TBL] [Abstract][Full Text] [Related]
7. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
8. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
9. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic effects of milrinone with and without a bolus loading infusion.
Baruch L; Patacsil P; Hameed A; Pina I; Loh E
Am Heart J; 2001 Feb; 141(2):266-73. PubMed ID: 11174341
[TBL] [Abstract][Full Text] [Related]
11. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
[TBL] [Abstract][Full Text] [Related]
12. [The effect of hemodynamic changes in 24-hour milrinone infusion on sympathetic activity and the renin-angiotensin-aldosterone system in patients with severe heart failure].
Mager G; Steffen HM; Klocke RK; Wambach G; Kux A; Degenhardt S; Höpp HW; Hilger HH
Z Kardiol; 1991 Apr; 80(4):272-8. PubMed ID: 1862668
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic effects of milrinone in the treatment of cardiac insufficiency after heart surgery with extracorporeal circulation].
Lançon JP; Caillard B; Obadia JF; Pillet M; Leblanc-Beaufils C; Le Bloch Y
Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1575-9. PubMed ID: 1763924
[TBL] [Abstract][Full Text] [Related]
14. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
15. [Hemodynamic effects of milrinone on patients with chronic congestive heart failure: a multicenter study. Cooperative Group for Phase II Clinical Trial of Milrinone].
Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):599-602. PubMed ID: 8697925
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of intravenous milrinone in the treatment of acute congestive cardiac failure. Results of a French multicenter study].
Dubois-Randé JL; Guérot C; Jan F; Brochier M; Sacrez A; Vacheron A; Bory M; Lambert H; Pony JC; Le Bloc'h Y
Ann Cardiol Angeiol (Paris); 1993 Feb; 42(2):105-14. PubMed ID: 8494318
[TBL] [Abstract][Full Text] [Related]
17. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
[TBL] [Abstract][Full Text] [Related]
18. Milrinone in the treatment of low output states following cardiac surgery.
Wright EM; Skoyles J; Sherry KM
Eur J Anaesthesiol Suppl; 1992; 5():21-6. PubMed ID: 1600964
[TBL] [Abstract][Full Text] [Related]
19. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
Meissner A; Schmelzle T; Simon R
Z Kardiol; 1996 Nov; 85(11):839-46. PubMed ID: 9064946
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
